VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1643091
Sex: M
Age:
State: CA

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 037C21A) for COVID-19 vaccination. Concurrent medical conditions included Hay fever. On 24-May-2021 at 4:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-May-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). The patient was treated with PARACETAMOL (TYLENOL) (oral) from 22-Jun-2021 to 26-Jun-2021 for Pain relief, at a dose of 800 mg. On 28-May-2021, OROPHARYNGEAL PAIN (sore throat) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were provided. Painful sore throat treated cough medicines and cough drops and sore throat sprays. Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Significant follow up contain reporter contact details, patient demographics, Allergies and event outcome are updated.

Other Meds:

Current Illness: Hay fever

ID: 1643092
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Sinus infection. Concurrent medical conditions included Pollen allergy. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection). The patient was treated with PREDNISONE ongoing since an unknown date for Sinus infection, at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection) had not resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant product used was not provided by the reporter. Patient was advised to hold off on the steroid until his second shot of vaccine. Treatment included local prednisone. This case was linked to MOD-2021-233333 (Patient Link).

Other Meds:

Current Illness: Pollen allergy

ID: 1643093
Sex: M
Age: 73
State: TN

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Medical history was not provided by reporter. Concomitant products included CHLORPHENAMINE MALEATE, PARACETAMOL (CORICIDIN HBP COLD AND FLU), PARACETAMOL (TYLENOL) and NAPROXEN SODIUM (ALEVE) for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. He scheduled for CT scan on 20-july-2021 and see an ear, nose, and throat specialist Physician on 7JUL2021. Treatment medications were not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments Action taken with mRNA-1273 in response to the events was not Applicable This case was linked to MOD-2021-232656, MOD-2021-233282 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on 23-jun-2021 contains no new information.

Other Meds: CORICIDIN HBP COLD AND FLU; TYLENOL; ALEVE

Current Illness:

ID: 1643094
Sex: M
Age:
State: CA

Vax Date: 06/22/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Needle might have leaked out; Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (Needle might have leaked out) and UNDERDOSE (Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, the patient experienced DEVICE CONNECTION ISSUE (Needle might have leaked out) and UNDERDOSE (Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose). On 22-Jun-2021, DEVICE CONNECTION ISSUE (Needle might have leaked out) and UNDERDOSE (Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided. Treatment information was not provided. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: No new information

Other Meds:

Current Illness:

ID: 1643095
Sex: U
Age:
State: TX

Vax Date: 06/22/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine to 3 patients which were withdrawn the night before ( more than 12 hours ago ).; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine to 3 patients which were withdrawn the night before ( more than 12 hours ago ).) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine to 3 patients which were withdrawn the night before ( more than 12 hours ago ).). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine to 3 patients which were withdrawn the night before ( more than 12 hours ago ).) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported. Patient identifier- Group of patients. Complaint Title :Expiration date on Vial Label Faded( Labelling issue). Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Non-Significant Follow-up On 29-Jun-2021: Non-Significant follow up appended to

Other Meds:

Current Illness:

ID: 1643096
Sex: U
Age:
State:

Vax Date: 06/22/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Very restless; Mild headache; woke up nauseaous; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (Very restless), HEADACHE (Mild headache) and NAUSEA (woke up nauseaous) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RESTLESSNESS (Very restless), HEADACHE (Mild headache) and NAUSEA (woke up nauseaous). At the time of the report, RESTLESSNESS (Very restless), HEADACHE (Mild headache) and NAUSEA (woke up nauseaous) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient had mild COVID-19 in march. No concomitant medication was reported. The treatment information was not given.

Other Meds:

Current Illness:

ID: 1643097
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: feel like I am going to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (feel like I am going to throw up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (feel like I am going to throw up). At the time of the report, VOMITING (feel like I am going to throw up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication not provided. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1643098
Sex: M
Age:
State: MT

Vax Date: 05/08/2021
Onset Date: 06/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: 1st dose we got may have been expired.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1st dose we got may have been expired.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 028A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jun-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (1st dose we got may have been expired.). On 23-Jun-2021, EXPIRED PRODUCT ADMINISTERED (1st dose we got may have been expired.) had resolved. No concomitant medication was reported. No treatment information was reported. This case was linked to MOD-2021-234082 (Patient Link).

Other Meds:

Current Illness:

ID: 1643099
Sex: M
Age:
State: MO

Vax Date: 06/22/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: received a dose from a vial that was expired; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose from a vial that was expired) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose from a vial that was expired). On 22-Jun-2021, EXPIRED PRODUCT ADMINISTERED (received a dose from a vial that was expired) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. Reporter stated that the patient have reported any adverse event after getting the vaccine shot. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643100
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: diarrhea; changed in bowel activity; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and FUNCTIONAL GASTROINTESTINAL DISORDER (changed in bowel activity) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and FUNCTIONAL GASTROINTESTINAL DISORDER (changed in bowel activity). At the time of the report, DIARRHOEA (diarrhea) and FUNCTIONAL GASTROINTESTINAL DISORDER (changed in bowel activity) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1643101
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: covid arm; extremely painful (arm); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (covid arm) and VACCINATION SITE PAIN (extremely painful (arm)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (covid arm) and VACCINATION SITE PAIN (extremely painful (arm)). At the time of the report, VACCINATION COMPLICATION (covid arm) and VACCINATION SITE PAIN (extremely painful (arm)) outcome was unknown. Not Provided Patient received second dose on March 30th.

Other Meds:

Current Illness:

ID: 1643102
Sex: M
Age: 81
State: CA

Vax Date: 01/30/2021
Onset Date: 06/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210621; Test Name: COVID-19; Test Result: Positive ; Result Unstructured Data: positive

Allergies:

Symptom List: Rash, Urticaria

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after first dose), FATIGUE and PRODUCT DOSE OMISSION ISSUE in an 82-year-old male patient who received mRNA-1273 (MODERNA COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included Stroke (occurred last year). Concomitant products included AMLODIPINE, ATORVASTATIN and METFORMIN for an unknown indication. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced COVID-19 (Tested positive for COVID-19 after first dose). On an unknown date, the patient experienced FATIGUE (Feeling tired) and PRODUCT DOSE OMISSION ISSUE (Over 42 days from first dose). At the time of the report, COVID-19 (Tested positive for COVID-19 after first dose) and FATIGUE (Feeling tired) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Over 42 days from first dose) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2021, SARS-CoV-2 test: positive (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medication was not reported.

Other Meds: AMLODIPINE; ATORVASTATIN; METFORMIN

Current Illness:

ID: 1643103
Sex: F
Age: 58
State: IL

Vax Date: 05/18/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: felt sick; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt sick) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B212A) for COVID-19 vaccination. No Medical History information was reported. On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced VACCINATION COMPLICATION (felt sick). At the time of the report, VACCINATION COMPLICATION (felt sick) outcome was unknown. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter This case was linked to MOD-2021-233047 (Patient Link).

Other Meds:

Current Illness:

ID: 1643104
Sex: U
Age:
State: LA

Vax Date: 06/08/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received on 23-jun-2021 contains No Significant information. Consent Follow up Declined.

Other Meds:

Current Illness:

ID: 1643105
Sex: F
Age: 58
State: IL

Vax Date: 06/22/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 06/22/2021; Test Name: Body temprature; Test Result: Inconclusive; Result Unstructured Data: 101.3?F.

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3?F) and terrible headache in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 009C21A) for COVID-19 immunization. No medical history reported. On Jun 22, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 22, 2021, patient experienced malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3?F) and terrible headache. At the time of the report, malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3?F) and terrible headache outcome: unknown. Diagnostic results: On Jun 22, 2021, Body temperature: 101.3?F (inconclusive). No concomitant medication or treatment information provided. This case linked to MOD-2021-233019 (patient link).

Other Meds:

Current Illness:

ID: 1643106
Sex: M
Age: 69
State: ID

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Red bumps that itch like crazy; Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck; Red bumps that itch like crazy; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Red bumps that itch like crazy), RASH (Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck) and RASH ERYTHEMATOUS (Red bumps that itch like crazy) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Red bumps that itch like crazy), RASH (Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck) and RASH ERYTHEMATOUS (Red bumps that itch like crazy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of 1 dosage form. At the time of the report, RASH PRURITIC (Red bumps that itch like crazy), RASH (Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck) and RASH ERYTHEMATOUS (Red bumps that itch like crazy) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported. Treatment had been treating with 3 different creams none seem to be getting rid of it.. Patient said that Provider's next suggestion is a Kenalog (steroid) shot, but not specified the patient has been taken. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up received on 29-JUN-2021 and does not contain any new information.

Other Meds:

Current Illness:

ID: 1643107
Sex: U
Age:
State:

Vax Date: 06/14/2021
Onset Date: 06/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: hot injection site; my injection site became swollen; red injection site; i also developed diarrhea; i had the normal arm pain for 24 hrs; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (i also developed diarrhea), VACCINATION SITE WARMTH (hot injection site), MYALGIA (i had the normal arm pain for 24 hrs), VACCINATION SITE SWELLING (my injection site became swollen) and VACCINATION SITE ERYTHEMA (red injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced MYALGIA (i had the normal arm pain for 24 hrs). On 15-Jun-2021, the patient experienced DIARRHOEA (i also developed diarrhea). On 20-Jun-2021, the patient experienced VACCINATION SITE WARMTH (hot injection site), VACCINATION SITE SWELLING (my injection site became swollen) and VACCINATION SITE ERYTHEMA (red injection site). On 15-Jun-2021, MYALGIA (i had the normal arm pain for 24 hrs) had resolved. At the time of the report, DIARRHOEA (i also developed diarrhea) had not resolved and VACCINATION SITE WARMTH (hot injection site), VACCINATION SITE SWELLING (my injection site became swollen) and VACCINATION SITE ERYTHEMA (red injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. No concomitant medications were reported. Patient reported no changes in her diet or anything.

Other Meds:

Current Illness:

ID: 1643108
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: does moderna vaccine cause lymph nodes to swell in your armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit). At the time of the report, LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided. Treatment medication was not provided.

Other Meds:

Current Illness:

ID: 1643109
Sex: U
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: I have developed random urticaria; I break out in a rash in random places on a daily basis; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (I have developed random urticaria) and RASH (I break out in a rash in random places on a daily basis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced URTICARIA (I have developed random urticaria) and RASH (I break out in a rash in random places on a daily basis). At the time of the report, URTICARIA (I have developed random urticaria) and RASH (I break out in a rash in random places on a daily basis) outcome was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1643110
Sex: M
Age: 54
State: PA

Vax Date: 06/22/2021
Onset Date: 06/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210623; Test Name: Body temperature; Result Unstructured Data: Increased; Comments: Raised to 105.3 and then went down to 102.5

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: bad headache; Fever/Temperature of 101-102, went up to 105.3/; he was uncontrollably shaking; he almost vomited; he was retching; Temperature went down to 102.5; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited) and RETCHING (he was retching) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited), RETCHING (he was retching) and PYREXIA (Temperature went down to 102.5). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited), RETCHING (he was retching) and PYREXIA (Temperature went down to 102.5) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, Body temperature: 101-102 Increased. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1643111
Sex: U
Age:
State:

Vax Date: 06/22/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: I have low grade temp; body ache; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (I have low grade temp) and MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have low grade temp) and MYALGIA (body ache). At the time of the report, PYREXIA (I have low grade temp) and MYALGIA (body ache) outcome was unknown.

Other Meds:

Current Illness:

ID: 1643112
Sex: F
Age:
State: GA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Tachycardia; Weakness; Body aches; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia), ASTHENIA (Weakness), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 040B21A) for COVID-19 vaccination. The patient's past medical history included Pre-diabetic. Concomitant products included OMEPRAZOLE, BROMURO DE PINAVERIO and SENNOSIDE A+B (SENOSIDOS AB) for an unknown indication. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced TACHYCARDIA (Tachycardia), ASTHENIA (Weakness), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg * 2 and ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, TACHYCARDIA (Tachycardia), ASTHENIA (Weakness), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment

Other Meds: OMEPRAZOLE; BROMURO DE PINAVERIO; SENOSIDOS AB

Current Illness:

ID: 1643113
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: 72 days since my first shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (72 days since my first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (72 days since my first shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (72 days since my first shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were provided For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1643114
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Losing your voice; Getting a cough; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (Losing your voice) and COUGH (Getting a cough) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APHONIA (Losing your voice) and COUGH (Getting a cough). At the time of the report, APHONIA (Losing your voice) and COUGH (Getting a cough) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Treatment medication was not provided.

Other Meds:

Current Illness:

ID: 1643115
Sex: U
Age:
State:

Vax Date:
Onset Date: 06/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Was really sick; White thrush on my tongue, down my throat (after second shot); Muscle pain after second shot; chills after second shot; Headache after second shot; Fever after second shot; This spontaneous case was reported by a consumer and describes the occurrence of ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ), ILLNESS (Was really sick), MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ) and HEADACHE (Headache after second shot ) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ), HEADACHE (Headache after second shot ) and PYREXIA (Fever after second shot ). On 23-Jun-2021, the patient experienced ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ). On an unknown date, the patient experienced ILLNESS (Was really sick). At the time of the report, ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ), ILLNESS (Was really sick), MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ), HEADACHE (Headache after second shot ) and PYREXIA (Fever after second shot ) outcome was unknown. No concomitant medication were reported. No treatment information was reported

Other Meds:

Current Illness:

ID: 1643116
Sex: F
Age:
State: GA

Vax Date: 05/05/2021
Onset Date: 06/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Weakness; Tachycardia; "Looks sick"; shortness of breath; Cold sores on lips; difficulty hearing from both ears; Anxiety; Body aches; "Stronger fever"; Headache; Chills; This spontaneous case was reported by a non-health professional and describes the occurrence of ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath) and ORAL HERPES (Cold sores on lips) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Prediabetes. Concomitant products included OMEPRAZOLE, PINAVERIUM BROMIDE and SENNA GLYCOSIDES for an unknown indication. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), ORAL HERPES (Cold sores on lips), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), MYALGIA (Body aches), PYREXIA ("Stronger fever"), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ORAL HERPES (Cold sores on lips), MYALGIA (Body aches) and PYREXIA ("Stronger fever") outcome was unknown and TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), HEADACHE (Headache) and CHILLS (Chills) had not resolved. No other treatment information was reported. This case was linked to MOD-2021-233164 (Patient Link).

Other Meds: OMEPRAZOLE; PINAVERIUM BROMIDE; SENNA GLYCOSIDES

Current Illness: Prediabetes

ID: 1643117
Sex: F
Age: 18
State: AR

Vax Date: 06/21/2021
Onset Date: 06/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: left arm sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (left arm sore) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced MYALGIA (left arm sore). At the time of the report, MYALGIA (left arm sore) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1643118
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: answered yes, to experiencing side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (answered yes, to experiencing side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (answered yes, to experiencing side effects). At the time of the report, VACCINATION COMPLICATION (answered yes, to experiencing side effects) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1643119
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Mild confusion; Anaemia; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia). At the time of the report, CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were mentioned. No treatment details were reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Additional information received on 29 June 2021 Included event Anemia and primary reporter contact details updated.

Other Meds:

Current Illness:

ID: 1643120
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: bit of shortness of breath; burping a lot at night; finger hurt; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (bit of shortness of breath), ERUCTATION (burping a lot at night) and PAIN IN EXTREMITY (finger hurt) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (bit of shortness of breath), ERUCTATION (burping a lot at night) and PAIN IN EXTREMITY (finger hurt). At the time of the report, DYSPNOEA (bit of shortness of breath), ERUCTATION (burping a lot at night) and PAIN IN EXTREMITY (finger hurt) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1643121
Sex: F
Age:
State: PR

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Patch testing; Test Result: Negative ; Result Unstructured Data: Patch testing came negative and physician concluded it could have been an Arthus reaction

Allergies:

Symptom List: Injection site pain

Symptoms: Tired; Headache; febrile; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Tired), HEADACHE (Headache) and PYREXIA (febrile) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to chemicals (methyl acrylates). Concomitant products included CANDESARTAN for Blood pressure, SIMVASTATIN for Hyperlipidemia, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Nasal allergy, CALCIUM, ASCORBIC ACID (VIT C) and GLUCOSAMINE for an unknown indication. On 30-Dec-2020 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired), HEADACHE (Headache) and PYREXIA (febrile). At the time of the report, FATIGUE (Tired), HEADACHE (Headache) and PYREXIA (febrile) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Skin test negative: negative (Negative) Patch testing came negative and physician concluded it could have been an Arthus reaction. No current illness, historical data was reported by patient. Treatment medication was not reported by patient. Patient went to immunologist for patch testing to ensure she was not allergic to an ingredient of vaccine in order to schedule the second dose. This case was linked to MOD-2021-003821 (Patient Link).

Other Meds: SIMVASTATIN; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; CANDESARTAN; CALCIUM; VIT C; GLUCOSAMINE

Current Illness: Allergy to chemicals (methyl acrylates)

ID: 1643122
Sex: F
Age: 68
State: CA

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: 101 degrees Fahrenheit

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: became very sick; diffuse/transient joint pain; Fever of 101 degrees Fahrenheit; inability to sleep/insomnia; GI symptoms; More than 42 days from first dose; swelling of entire left arm; This spontaneous case was reported by a physician and describes the occurrence of INSOMNIA (inability to sleep/insomnia), PERIPHERAL SWELLING (swelling of entire left arm), ABDOMINAL DISCOMFORT (GI symptoms), PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose) and ILLNESS (became very sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0411.20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Hormone replacement therapy. Concurrent medical conditions included Autoimmune disorder (Autoimmune/hyperimmune disorder), Lyme disease (Chronic) and Thyroid disorder NOS. Concomitant products included ESTRADIOL (ESTROGEN) for Hormone replacement therapy, LEVOTHYROXINE for Thyroid disorder NOS, ATENOLOL for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (swelling of entire left arm). On 02-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose). On 03-Mar-2021, the patient experienced INSOMNIA (inability to sleep/insomnia), ABDOMINAL DISCOMFORT (GI symptoms) and PYREXIA (Fever of 101 degrees Fahrenheit). On 09-Mar-2021, the patient experienced ARTHRALGIA (diffuse/transient joint pain). On an unknown date, the patient experienced ILLNESS (became very sick). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 02-Mar-2021, PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose) had resolved. On 04-Mar-2021, PYREXIA (Fever of 101 degrees Fahrenheit) had resolved. On 07-Mar-2021, PERIPHERAL SWELLING (swelling of entire left arm) had resolved. On 17-Mar-2021, ABDOMINAL DISCOMFORT (GI symptoms) had resolved. On 10-Jun-2021, INSOMNIA (inability to sleep/insomnia) had resolved. At the time of the report, ILLNESS (became very sick) and ARTHRALGIA (diffuse/transient joint pain) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (abnormal) 101 degrees Fahrenheit. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non significant follow up received. Patient is querying mailing address to print out the form and mail it as she doesn't have a scan or fax available. On 21-Jul-2021: Follow up received. It provides no new information.

Other Meds: LEVOTHYROXINE; ATENOLOL; ESTROGEN

Current Illness: Autoimmune disorder (Autoimmune/hyperimmune disorder); Lyme disease (Chronic); Thyroid disorder NOS

ID: 1643123
Sex: U
Age:
State:

Vax Date: 05/08/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1643124
Sex: U
Age:
State:

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Dizziness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness). The patient was treated with VITAMIN C [ASCORBIC ACID] ongoing since an unknown date at a dose of 1 dosage form; VITAMIN D [VITAMIN D NOS] ongoing since an unknown date at a dose of 1 dosage form; VITAMIN B NOS ongoing since an unknown date at a dose of 1 dosage form; UBIDECARENONE (COQ10 [UBIDECARENONE]) ongoing since an unknown date at a dose of 1 dosage form and MAGNESIUM GLYCINATE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. It was reported that patient stopped drinking diet soda and used glasses that blocks blue light. Concomitant medications were not provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2021-232184 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-232184:Other patient who reported events after Moderna vaccine

Other Meds:

Current Illness:

ID: 1643125
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: fever; body ache; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever) and MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and MYALGIA (body ache). At the time of the report, PYREXIA (fever) and MYALGIA (body ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication and treatment information provided.

Other Meds:

Current Illness:

ID: 1643126
Sex: M
Age: 70
State: NV

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of allergy to vaccine (allergic) and fatigue (just a little tired) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 031L20A) for COVID-19 immunization. No medical history reported. On Jan 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 18, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 21, 2021, patient experienced allergy to vaccine (allergic) and fatigue (just a little tired). On Jan 22, 2021, allergy to vaccine (allergic) and fatigue (just a little tired) resolved. mRNA-1273 (Moderna COVID-19 vaccine), unknown, and mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: dosing remained unchanged. No concomitant medication or treatment information provided. This case linked to MOD-2021-233289 (patient link).

Other Meds:

Current Illness:

ID: 1643127
Sex: U
Age:
State: CA

Vax Date: 06/22/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: no adverse event; Vaccine that was expired on 20Jun2021 was administered to 4 patients on 22Jun2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that was expired on 20Jun2021 was administered to 4 patients on 22Jun2021) and NO ADVERSE EVENT (no adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that was expired on 20Jun2021 was administered to 4 patients on 22Jun2021). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that was expired on 20Jun2021 was administered to 4 patients on 22Jun2021) had resolved and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication provided. no treatment medication provided. It was reported that there was no adverse events/adverse outcomes resulted from this expired Moderna during their second vaccinations. Most recent FOLLOW-UP information incorporated above includes: On 14-Aug-2021: follow up document received on 16-08-21 with new information.

Other Meds:

Current Illness:

ID: 1643128
Sex: U
Age:
State:

Vax Date: 06/23/2021
Onset Date: 06/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of hypoesthesia (slight numbness in feet & sole of feet) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jun 23, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19vaccine), unknown route; 1 dosage form. On Jun 23, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced hypoesthesia (slight numbness in feet & sole of feet). At the time of the report, hypoesthesia (slight numbness in feet & sole of feet): not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided.

Other Meds:

Current Illness:

ID: 1643129
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: can you get side effects next day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (can you get side effects next day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (can you get side effects next day). At the time of the report, VACCINATION COMPLICATION (can you get side effects next day) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1643130
Sex: F
Age: 59
State: TN

Vax Date: 02/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Slight headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Slight headache). On 09-Mar-2021, HEADACHE (Slight headache) had resolved. No Concomitant medication was reported. No Treatment medication was reported. This case was linked to MOD-2021-232713 (Patient Link).

Other Meds:

Current Illness:

ID: 1643131
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: If i got the first dose but it's been six weeks, do i have to start over with the first dose again?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (If i got the first dose but it's been six weeks, do i have to start over with the first dose again?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (If i got the first dose but it's been six weeks, do i have to start over with the first dose again?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (If i got the first dose but it's been six weeks, do i have to start over with the first dose again?) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1643132
Sex: F
Age: 21
State: FL

Vax Date: 06/04/2021
Onset Date: 06/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: a rash on her both thighs / now is on her arm, chest, stomach, back, which she still has.; big red patches; it looks like hives; This spontaneous case was reported by a consumer and describes the occurrence of RASH (a rash on her both thighs / now is on her arm, chest, stomach, back, which she still has.), ERYTHEMA (big red patches) and URTICARIA (it looks like hives) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. No medical history was provided by the reporter. The patient's past medical history included No adverse reaction. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication. On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced RASH (a rash on her both thighs / now is on her arm, chest, stomach, back, which she still has.), ERYTHEMA (big red patches) and URTICARIA (it looks like hives). At the time of the report, RASH (a rash on her both thighs / now is on her arm, chest, stomach, back, which she still has.), ERYTHEMA (big red patches) and URTICARIA (it looks like hives) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: VITAMINS A & D

Current Illness:

ID: 1643133
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Still tested positive after getting Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Still tested positive after getting Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Still tested positive after getting Moderna vaccine). At the time of the report, COVID-19 (Still tested positive after getting Moderna vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment information was reported.

Other Meds:

Current Illness:

ID: 1643134
Sex: M
Age: 70
State: NV

Vax Date: 01/21/2021
Onset Date: 02/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Within an hour I had four hives in all my body, except face, pubic area, throat and rectum; Itchiness in all my body; Lips swelling; My teeth were dumb; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Within an hour I had four hives in all my body, except face, pubic area, throat and rectum), PRURITUS (Itchiness in all my body), LIP SWELLING (Lips swelling) and DENTAL DISCOMFORT (My teeth were dumb) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced URTICARIA (Within an hour I had four hives in all my body, except face, pubic area, throat and rectum), PRURITUS (Itchiness in all my body), LIP SWELLING (Lips swelling) and DENTAL DISCOMFORT (My teeth were dumb). The patient was treated with COLLOIDAL BATH ongoing since an unknown date at a dose of UNK dosage form; PREDNISONE ongoing since an unknown date for Itching, at a dose of UNK dosage form; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) ongoing since an unknown date at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL TOTAL) ongoing since an unknown date at an unspecified dose and frequency. On 19-Feb-2021, LIP SWELLING (Lips swelling) and DENTAL DISCOMFORT (My teeth were dumb) had resolved. At the time of the report, URTICARIA (Within an hour I had four hives in all my body, except face, pubic area, throat and rectum) and PRURITUS (Itchiness in all my body) had resolved. No concomitants were provided. This case was linked to MOD-2021-233268 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2021: NNI follow-up. no new information received

Other Meds:

Current Illness:

ID: 1643135
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: reporting an adverse event as the patient declined to provide any information; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reporting an adverse event as the patient declined to provide any information) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reporting an adverse event as the patient declined to provide any information). At the time of the report, VACCINATION COMPLICATION (reporting an adverse event as the patient declined to provide any information) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. no relevant concomitant product was reported. no treatment product was reported.

Other Meds:

Current Illness:

ID: 1643136
Sex: U
Age:
State: MA

Vax Date:
Onset Date: 06/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: an expired vaccine (34 days in the refrigerator) was given to 57 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (an expired vaccine (34 days in the refrigerator) was given to 57 patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (an expired vaccine (34 days in the refrigerator) was given to 57 patients). On 23-Jun-2021, EXPIRED PRODUCT ADMINISTERED (an expired vaccine (34 days in the refrigerator) was given to 57 patients) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment information provided. The reported states that the Moderna covid-19 vaccine was left in the refrigerator for more than 30 days. The 30th day mark was on 19JUN2021 and the vaccine was administered from 20JUN2021 till today 23JUN2021 to a total of 57 patients.

Other Meds:

Current Illness:

ID: 1643137
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Sinus infection after first dose; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection after first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. Concurrent medical conditions included Allergy (allergies for the last 20 years that are on and off) and Pollen allergy (Sinus infections from pollen.). Concomitant products included METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Allergy. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection after first dose). The patient was treated with PREDNISONE for Sinus infection, at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection after first dose) had not resolved. Patient was advised to stop Medrol until he receive dose-2. Reporter did not allow further contact

Other Meds: MEDROL [METHYLPREDNISOLONE]

Current Illness: Allergy (allergies for the last 20 years that are on and off); Pollen allergy (Sinus infections from pollen.)

ID: 1643138
Sex: F
Age: 42
State: AR

Vax Date: 06/21/2021
Onset Date: 06/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202106; Test Name: temperature; Result Unstructured Data: 99 degree Farenheight temperature

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: the red area is the size of a golf ball; non stop headaches; chills; nausea; injection site is red; injection site is swollen; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (the red area is the size of a golf ball), HEADACHE (non stop headaches), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE ERYTHEMA (injection site is red) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history information was reported. Concomitant products included PARACETAMOL (TYLENOL) and IBUPROFEN for an unknown indication. On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In June 2021, the patient experienced VACCINATION SITE MASS (the red area is the size of a golf ball), HEADACHE (non stop headaches), CHILLS (chills), NAUSEA (nausea), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen). At the time of the report, VACCINATION SITE MASS (the red area is the size of a golf ball), HEADACHE (non stop headaches), CHILLS (chills), NAUSEA (nausea), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Body temperature: 99 (High) 99 degree Farenheight temperature. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided.

Other Meds: TYLENOL; IBUPROFEN

Current Illness:

ID: 1643139
Sex: F
Age: 77
State:

Vax Date: 01/15/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210506; Test Name: Blood test; Result Unstructured Data: After two bood test, the patient has no antibodies whatsoever; Test Name: antibodies test; Test Result: Negative ; Result Unstructured Data: negative

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: after receiving 2 doses of the Moderna COVID-19 Vaccine had 2 blood test and said that has No antibodies what so ever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION FAILURE (after receiving 2 doses of the Moderna COVID-19 Vaccine had 2 blood test and said that has No antibodies what so ever) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 025L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included SIMVASTATIN, LEVOTHYROXINE, TRAMADOL and OMEPRAZOLE for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION FAILURE (after receiving 2 doses of the Moderna COVID-19 Vaccine had 2 blood test and said that has No antibodies what so ever). At the time of the report, VACCINATION FAILURE (after receiving 2 doses of the Moderna COVID-19 Vaccine had 2 blood test and said that has No antibodies what so ever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Blood test: no antibodies found (normal) After two bood test, the patient has no antibodies whatsoever. On an unknown date, Antibody test: negative (Negative) negative. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Treatment medication were not provided. The patient reported that she had underwent blood tests on 06 May 2021 and second date was unknown. The patient reported that she has no antibodies reported after the blood test. This is a case of vaccination failure (no antibodies response detected) without adverse events. Causality is not applicable.; Sender's Comments: This is a case of vaccination failure (no antibodies response detected) without adverse events. Causality is not applicable.

Other Meds: SIMVASTATIN; LEVOTHYROXINE; TRAMADOL; OMEPRAZOLE

Current Illness:

ID: 1643140
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: patient recieved a moderna vaccine and they were under the age of 18; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient recieved a moderna vaccine and they were under the age of 18) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient recieved a moderna vaccine and they were under the age of 18). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient recieved a moderna vaccine and they were under the age of 18) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am